A Congressional committee may subpoena the CEOs of Johnson & Johnson and Merck & Co. to testify about the differences...
Medicine
A radiopharmaceutical drug from Novartis kept a rare type of neuroendocrine cancer at bay for longer than did standard therapy,...
Jaguar Gene Therapy is spinning out part of its business to handle the specialized work of manufacturing cell and gene...
Mirae Asset Capital Life Science, a new venture capital fund, launched on Thursday, joining several other new firms that have...
Dive Brief: Kyverna Therapeutics on Tuesday revealed plans to go public, testing the waters in a biotechnology market that hasn’t...
Dive Brief: Massachusetts-based startup Comanche BioPharma has raised $75 million in new venture funding to advance an experimental treatment targeting...
Relationships with Speaker Bureau faculty are among the most important that a biopharmaceutical company nurtures. These relationships often span multiple...
The Food and Drug Administration on Tuesday approved Vertex Pharmaceuticals’ CRISPR-based medicine Casgevy for the inherited blood condition beta thalassemia, expanding...
San Diego-drugmaker Dare Bioscience describes itself as the rare biotechnology company focused exclusively on women’s health, a category it says...
Over the span of five months, biotechnology startup Aiolos Bio launched, raised initial funding from venture investors and negotiated a...